Literature DB >> 8583849

Vocal cord injection with autogenous fat: a long-term magnetic resonance imaging evaluation.

J H Brandenburg1, J M Unger, D Koschkee.   

Abstract

Since 1987, the senior author has injected autogenous fat into paralyzed or atrophic vocal cords as an alternative to alloplastic substances for vocal cord augmentation and medialization. To determine the fate of the injected autogenous fat, the injected vocal cords of 10 patients were evaluated by laryngeal magnetic resonance imaging (MRI) in the sagittal, coronal, and axial planes. Imaging studies were performed as early as 17 hours after surgery to as long as 31 months after fat injection. In 9 patients, identification of a fat signal within the previously injected vocal cords was observed (including the 31-month postoperative follow-up). In 1 patient, no fat signal was identified 13 months after surgery, but the vocal cord was noted to have a bulging, enlarged contour. The results of this imaging study provide further evidence that autogenous fat, which has not been damaged during harvesting or microinjection, can survive transplantation into the vocal cord. The bulk of the vocal cord is maintained by microlipocytes and fibrous connective tissue, both of which replace the damaged fat cells that are gradually being reabsorbed.

Entities:  

Mesh:

Year:  1996        PMID: 8583849     DOI: 10.1097/00005537-199602000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  13 in total

1.  Evaluation of alloderm and autologous skin in quadriceps muscles of rats for injection laryngoplasty.

Authors:  A Sengor; O Aydin; F Mola; Y Gürbüz
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-02-18       Impact factor: 2.503

2.  CT assessment of vocal cord medialization.

Authors:  V A Kumar; J S Lewin; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

Review 3.  [Vocal fold augmentation].

Authors:  C Sittel; P K Plinkert
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

4.  Multiparameter comparison of injection laryngoplasty, medialization laryngoplasty, and arytenoid adduction in an excised larynx model.

Authors:  Matthew R Hoffman; Rachel E Witt; William J Chapin; Timothy M McCulloch; Jack J Jiang
Journal:  Laryngoscope       Date:  2010-04       Impact factor: 3.325

5.  Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis.

Authors:  A Ricci Maccarini; M Stacchini; F Mozzanica; A Schindler; E Basile; G DE Rossi; P Woo; M Remacle; M Magnani
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

6.  Autogenous fat injection for vocal fold atrophy.

Authors:  Ming-Wang Hsiung; Yaoh-Shiang Lin; Wan-Fu Su; Hsing-Won Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-08       Impact factor: 2.503

7.  The neocartilaginous formation with hydroxyl-apatite in injection laryngoplasty: an experimental study on rabbit model.

Authors:  Erkan Ozudogru; Hamdi Cakli; Esin Asan; Cemal Cingi; Kezban Gurbuz; Aytekin Yaz; Beklen Ure
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-20       Impact factor: 2.503

Review 8.  [Surgical voice rehabilitation in unilateral vocal fold paralysis].

Authors:  C Sittel; N Bosch; P K Plinkert
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

9.  Treatment of velopharyngeal insufficiency by autologous fat injection.

Authors:  Igor Leuchter; Valérie Schweizer; Judith Hohlfeld; Philippe Pasche
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-23       Impact factor: 2.503

10.  Phonosurgery after endoscopic cordectomies. I. Primary intracordal autologous fat injection after transmuscular resection: preliminary results.

Authors:  Andrea Bolzoni Villaret; Cesare Piazza; Luca Oscar Redaelli De Zinis; Augusto Cattaneo; Daniela Cocco; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-30       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.